Impact of hepatitis B birth dose on immune response in Pakistani children: an open-label, non-inferiority randomized controlled trial, implications for achieving SDG target-Reference-Cited by-同舟云学术

Impact of hepatitis B birth dose on immune response in Pakistani children: an open-label, non-inferiority randomized controlled trial, implications for achieving SDG target

Published:2023-09-15 Issue:1 Volume:56 Page:1-10
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Gorar Zulfikar Ali¹,Butt Zahid Ahmad²

Affiliation:

1. Health Services Academy, Islamabad, Pakistan

2. School of Public Health Sciences, University of Waterloo, Waterloo, Canada

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2023.2258208

Reference41 articles.

1. Bloomberg BS, Hepatitis B. The hunt for a killer virus. 1st ed. Princeton (NJ): Princeton University Press; 2003.

2. Hepatitis B vaccines: WHO position paper – July 2017;World Health Organization;Releve Epidemiol Hebd,2017

3. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

4. United Nations. Global indicator framework for the sustainable development goals and targets of the 2030 agenda for sustainable development [Internet]. Work of the Statistical Commission pertaining to the 2030 Agenda for Sustainable Development. 2017. p. 1–21. Available from: https://unstats.un.org/sdgs/indicators/Global Indicator Framework_A.RES.71.313 Annex.pdf.

5. World Health Organization. Global health sector strategy viral hepatitis 2016–2021. Geneva (Switzerland): WHO Press; 2016.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Vaccine: Four Decades on;Vaccines;2024-04-18